Trans Away The Gay: Gender-Affirming Care IS Conversion Therapy | Scott Newgent
13 October 2026
With Scott Newgent
UK
Scott Newgent, who underwent sex-altering procedures and now lives with severe medical complications, tells Mia Hughes how homophobia from a partner, a trans-identified therapist and a gynaecologist's unverified intersex claim pushed her toward transition. The episode sets out why affirmation-first care can function as conversion therapy for gay and lesbian people, and why Newgent is travelling to the UK Parliament on 21 October to argue against a proposed conversion therapy ban she says would criminalise legitimate exploratory therapy while shielding gender-identity medicine from scrutiny.
Scott Newgent is an American patient advocate who underwent extensive sex-altering medical procedures and has spoken publicly for several years about the severe physical complications that followed. In this episode, she tells Mia Hughes the story behind her transition: a difficult relationship dynamic, a therapist who was herself trans-identified, and a gynaecologist who, without conducting tests, suggested she might be intersex. Newgent describes how these encounters compounded a sense of not belonging and steered her toward a medical pathway she says was never adequately scrutinised before she began it. The conversation pairs Newgent's personal account with the medical aftermath she has lived through, describing the physical and psychosocial toll of procedures she now characterises as cosmetic rather than life-saving. Her case is offered as an illustration of a pattern raised repeatedly in the evidence underlying youth and adult gender medicine: that affirmation can proceed with little differential diagnosis, and that complications are often minimised in advance and inadequately tracked afterward. Systematic reviews commissioned in several European jurisdictions, including the Cass Review in England, have similarly found that evidence for medical transition as a treatment for gender-related distress is of low certainty, and that underlying conditions, including same-sex attraction, are frequently insufficiently explored before treatment begins. A central argument in the episode is that gender-affirming pathways can function as a form of conversion practice against gay and lesbian people, steering same-sex attracted individuals toward medical transition rather than supporting them to accept their sexuality. This claim has gained traction in European regulatory debates, where some clinicians and detransitioners have reported that homophobia, overt or internalised, played a role in their own or their patients' pursuit of transition. Newgent's account of a trans-identified therapist and a gynaecologist's unverified intersex suggestion adds a specific, personal illustration to this broader concern about diagnostic rigour in gender clinics. The episode's most immediate policy relevance lies in the UK. Newgent is due to address Parliament on 21 October, ahead of a vote on a proposed ban on so-called conversion therapy. Critics of the bill, including Newgent, argue that its definitions are broad enough to criminalise exploratory psychotherapy, including the kind of careful, non-directive conversation that might have changed her own trajectory, while leaving affirmation-only approaches untouched. Similar legislative proposals have been debated or enacted in other European countries, and the tension between protecting people from coercive attempts to change sexual orientation and preserving space for open-ended therapeutic exploration of gender distress is a recurring theme in law-and-policy debates across the continent. For readers tracking the evidence base, Newgent's testimony is not a clinical study, but it intersects with documented concerns: inadequate differential diagnosis, insufficient attention to co-occurring same-sex attraction, and the long-term consequences of irreversible procedures undertaken without full information. Her upcoming parliamentary appearance places a patient's lived experience directly into a live UK legislative process with implications for how European jurisdictions define and regulate conversion therapy.
